IL18 and hepatitis C virus infection: Therefore, we aimed to establish a highly sensitive time‐resolved fluorescence immunoassay (TRFIA)14 and evaluate its application for detecting IL‐18 in the serum of liver cancer, hepatitis B, hepatitis C, autoimmune hepatitis, and fatty liver disease patients.